Cresco Labs (CRLBF) Free Cash Flow (2020 - 2026)
Cresco Labs (CRLBF) posted Free Cash Flow of $7.6 million for Q1 2026, up 122.58% on a QoQ basis from -$33.8 million in Q4 2025, and up 31.28% year-over-year from $5.8 million in Q1 2025.
Cresco Labs (CRLBF) Free Cash Flow (2020 - 2026) Analysis & Trends
Cresco Labs' Free Cash Flow history runs 7 years deep, the most recent figure standing at $7.6 million for Q1 2026.
- Quarterly Free Cash Flow rose 31.28% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $278000.0 (down 99.67% YoY) and the FY2025 annual result came in at $37.8 million, down 71.4% from the prior year.
- Free Cash Flow was $7.6 million for Q1 2026 at Cresco Labs, up from -$33.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $55.4 million in Q3 2024 and bottomed at -$149.3 million in Q4 2022.
- A 5-year average of $741176.5 and a median of $12.7 million in 2024 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 800.96% in 2025, while the deepest fall reached 366.19% in 2025.
- Cresco Labs' Free Cash Flow stood at -$149.3 million in 2022, then increased by 26.82% to -$109.3 million in 2023, then soared by 111.63% to $12.7 million in 2024, then slumped by 366.19% to -$33.8 million in 2025, then soared by 122.58% to $7.6 million in 2026.
- Business Quant data shows CRLBF's Free Cash Flow at $7.6 million in Q1 2026, -$33.8 million in Q4 2025, and $13.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.64 Mn |
| Mar 31, 2026 | 7.64 Mn |
| Dec 31, 2025 | -33.83 Mn |
| Dec 31, 2025 | -33.83 Mn |
| Sep 30, 2025 | 13.34 Mn |
| Sep 30, 2025 | 13.34 Mn |
| Jun 30, 2025 | 13.12 Mn |
| Jun 30, 2025 | 13.12 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Mar 31, 2025 | 5.82 Mn |
| Dec 31, 2024 | 12.71 Mn |
| Dec 31, 2024 | 12.71 Mn |
| Sep 30, 2024 | 55.44 Mn |
| Sep 30, 2024 | 55.44 Mn |
| Jun 30, 2024 | 11.05 Mn |
| Jun 30, 2024 | 11.05 Mn |
| Mar 31, 2024 | -830,000.00 |
| Mar 31, 2024 | -830,000.00 |
| Dec 31, 2023 | -109.25 Mn |
| Dec 31, 2023 | -109.25 Mn |